DELASOL®

DELASOL®
Product Description

DELASOL® is a gelatin product for the one-step production of truly enteric capsules that open in the intestine (instead of the stomach, as with traditional gelatine capsules).
Most enteric delivery systems are produced by applying an acid-insoluble coating to freshly produced soft capsules. This intensive two-step process adds time and money to the cost of each enteric capsule. Additionally, this coating produces an opaque shell – which is less desired by consumers.

With DELASOL®, capsules producers now have the ability to create enteric capsules using existing equipment in a one-step process – avoiding additional time and costs – while creating brilliantly clear capsules.

Read more Show less

GELITA AG

  • DE
  • 2023
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Primary activities
Excipients Manufacturer
View company profile
Categories
more categories Show less

GELITA AG

  • DE
  • 2023
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Primary activities
Excipients Manufacturer
View company profile

More Products from GELITA AG (2)

  • EASYSEAL®

    Product EASYSEAL®

    A new era of softgel production has begun. EASYSEAL® is a unique solution that enables manufacturers to optimize their process in one easy step. By switching to new EASYSEAL® gelatin, you can enjoy significant reductions in leakers, lower processing costs and higher quality end products.

    S...
  • RXL® Ultra

    Product RXL® Ultra

    With RXL® Ultra, GELITA re-focusses on an established, but un-noticed, solution to conquer crosslinking challenges. As part of the RXL® product portfolio, the modified gelatin RXL® Ultra is the benchmark in anti-crosslinking performance for gelatin based excipients. While maintaining the known benefits...

GELITA AG resources (1)

  • Heavy Crosslinking Due to Novel Plant Extracts – Challenge Accepted With Rxl® Ultra

    Video Heavy Crosslinking Due to Novel Plant Extracts – Challenge Accepted With Rxl® Ultra

    Existing and upcoming trends for plant-based extracts represent a challenge for softgel manufacturers – as potential extreme crosslinking components. With RXL® Ultra, GELITA re-focusses on an established, but hidden/un-noticed, solution to conquer these crosslinking challenges. As part of the RXL®-product family, the modified gelatin RXL® Ultra is the benchmark in anti-crosslinking performance for gelatin based excipients. While maintaining the known benefits in softgel production for gelatin, it provides ultimate potential to solve even extreme crosslinking and – in the end – deliver reliable products to the consumer. This session will also provide insights on the regulatory background for RXL® Ultra and how to overcome challenges when used as capsule material.
    2024-10-25